-
Review of Rare Disease Policy Developments in Europe and Türkiye 2020-2025 in the Context of Innovative Orphan Drugs
Sep 9, 2025, 16:22 PM -
A Proof of Concept Study to Build a Japanese-Based Electronic Medical Record Data Model Suited for Real-World Research
Sep 9, 2025, 16:22 PM -
The Value of Persistence in Neovascular Age-Related Macular Degeneration
Sep 9, 2025, 16:22 PM -
The Intercept of Real-World Evidence (RWE) Health Equity and Health Technology Assessment (HTA): A Structured Literature Review of Health Policy and Methodological Guidance
Sep 9, 2025, 16:22 PM -
Real-World Insights From the LOGEX IMID Observatory: A Multicountry, Multiyear Analysis of Treatment Pathways and Healthcare Resource Utilization in Immune-Mediated Inflammatory Diseases
Sep 9, 2025, 16:22 PM -
Improving Patient Flow and Multidisciplinary Coordination in Urothelial Carcinoma: Insights From Bulgarian Oncologists
Sep 9, 2025, 16:22 PM -
Market Access AI Readiness: Maximizing Strategic Alignment Through Organizational Insights
Sep 9, 2025, 16:22 PM -
Cross-Validation of the Glycated Hemoglobin HbA1c Translator: A Predictive Tool to Evaluate the Relationship Between Diabetes Complications and Associated Healthcare Costs
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of TEVAR With Active Control in Patients With TAA and TBAD: A Japanese Public Healthcare Payer Perspective
Sep 9, 2025, 16:22 PM -
Are Glucagon-Like Peptide-1 Receptor Agonists Prescribed for Weight Loss Slipping Through the Net of Japan’s Strict Guidelines? An Analysis of Health Insurance Claims Data
Sep 9, 2025, 16:22 PM -
Are We SEEing It Yet? The Use of Structured Expert Elicitation Protocols for Decision Making
Sep 9, 2025, 16:22 PM -
Late Treatment in Adults With Neurogenic Bowel Dysfunction: A Retrospective Analysis of German Claims Data
Sep 9, 2025, 16:22 PM -
Impact of Different Thresholds of Increasing or Decreasing Body Mass Index on Noncommunicable Diseases Through a Discrete Event Simulation Model
Sep 9, 2025, 16:22 PM -
Reducing Healthcare Costs and Addressing Health Equity Through Improved Treatment Adherence and Reduced Exacerbation Risk in Chronic Obstructive Pulmonary Disease: Real-World Evidence From a Danish Nationwide Cohort Study
Sep 9, 2025, 16:22 PM -
Healthstate Utilities for Hormone Receptor-Positive (HR+) Human Epidermal Growth Factor-Receptor 2 Negative (HER2-) Breast Cancer
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Synovial Biopsy-Guided Treatment Strategy After TNF-Alpha Inhibitor Failure in Rheumatoid Arthritis
Sep 9, 2025, 16:22 PM -
Budget Impact of Including Cannabis-Based Products in Brazil’s Public Health System: A Scenario Analysis
Sep 9, 2025, 16:22 PM -
Examining Knowledge Regarding Needlestick Injuries Among Students in Higher Healthcare Education
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Contemporary First-Line (1L) Treatments for Locally Advanced or Metastatic Urothelial Carcinoma La/mUC in France: A Sensitivity Analysis
Sep 9, 2025, 16:22 PM -
Beyond the Guidelines: Exploring the Characteristics and Comorbidity Profiles of Adults With Pneumococcal Disease in England Not Covered by Current Pneumococcal Vaccination Criteria
Sep 9, 2025, 16:22 PM
